The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Achievement of cancer- and treatment-free status by atezolizumab plus bevacizumab combined with or without curative conversion in patients with transarterial chemoembolization-unsuitable, intermediate-stage hepatocellular carcinoma: A multicenter cohort study.
 
Masatoshi Kudo
Honoraria - Bayer; Chugai/Roche; Eisai; Lilly Japan; Takeda
Research Funding - Abbvie (Inst); Chugai/Roche; EA Pharma (Inst); Eisai (Inst); GE Healthcare; Otsuka (Inst); Taiho Pharmaceutical (Inst)
 
Tomoko Aoki
No Relationships to Disclose
 
Kazuomi Ueshima
No Relationships to Disclose
 
Kaoru Tsuchiya
Consulting or Advisory Role - Chugai Pharma; Eisai
Speakers' Bureau - Chugai Pharma; Eisai; Lilly Japan; Takeda
 
Masahiro Morita
No Relationships to Disclose
 
Satoru Hagiwara
No Relationships to Disclose
 
Yasunori Minami
No Relationships to Disclose
 
Hiroshi Ida
No Relationships to Disclose
 
Naoshi Nishida
No Relationships to Disclose
 
CHIKARA OGAWA
No Relationships to Disclose
 
Tetsu Tomonari
No Relationships to Disclose
 
Noriaki Nakamura
No Relationships to Disclose
 
Hidekatsu Kuroda
No Relationships to Disclose
 
Atsushi Takebe
No Relationships to Disclose
 
Yoshifumi Takeyama
No Relationships to Disclose
 
Masaaki Hidaka
No Relationships to Disclose
 
Susumu Eguchi
No Relationships to Disclose
 
Stephen Lam Chan
Honoraria - AstraZeneca; Eisai; Ipsen; MSD; Roche
Consulting or Advisory Role - AstraZeneca; BMS; Eisai; MSD Oncology; Roche
Research Funding - Bayer; Eisai; Ipsen; MSD; Sirtex Medical
 
Masayuki Kurosaki
Speakers' Bureau - Abbvie; Chugai Pharma; Eisai; Gilead Sciences; Janssen; Lilly Japan; Takeda
 
Namiki Izumi
Honoraria - Bayer; Chugai Pharma; Eisai; Lilly; Takeda